By Ateev Bhandari Feb 19 (Reuters) - Wall Street broker Clear Street on Thursday pulled its U.S. listing plan a week after ...

EIR Biopharma is hoping to bring in $17.1 million from an IPO on the New York Stock Exchange that could fund development of its preclinical eye disease drug. | EIR Biopharma is hoping to bring in $17.

SpaceX is going public soon, but experts warn against common pitfalls for investors hoping to make a quick profit. Learn what ...

For U.S. initial public offerings, 2026 is starting out as a slow burn, with 24 IPOs filed so far, down 11.1% from the same ...

By Rashika Singh Feb 9 (Reuters) - U.S. equity markets are set for a sharp rebound in IPOs in 2026, Goldman Sachs analysts ...

By Praveen Paramasivam Feb 20 (Reuters) - Indian dairy products maker Milky Mist will push ahead with its planned initial ...

Passing qualification one no longer guarantees anything beyond continued review. Yet many companies still build IPO plans as if meeting these metrics alone guarantees a listing outcome and sporadic ...

TY AM Group seeks an $18.75 million U.S. IPO despite sharply slowing revenue growth and extreme customer concentration. Click ...

SpaceX's planned 2026 IPO could be good news for space stocks -- but it will more likely be bad news.

BlockDAG ($BDAG), or Bitcoin Hyper be the strongest upside presales in 2026, or is one simply louder than the rest?

Discover what venture capital-backed IPOs are, how they work, and their impact on investors. Learn about key examples like ...